Johann Jonsson
Overview
Explore the profile of Johann Jonsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Palsson T, Andresdottir M, Jonsson E, Jonsson J, Hilmarsson R, Indridason O, et al.
Front Transplant
. 2024 Jul;
3:1398444.
PMID: 38993778
Background: In Iceland, a small number of kidney transplants from living donors (LDs) are performed at Landspitali University Hospital (LUH) in Reykjavik, while deceased donor transplants have until recently invariably...
2.
Siskind E, Liu C, Collins D, Emery E, Steen E, Tran E, et al.
Pancreas
. 2019 May;
48(5):644-651.
PMID: 31091210
Objectives: Mammalian targets of rapamycin inhibitors (mTORi) are considered second-line immunosuppression agents because of associated increases in rejection and impaired wound healing. Recent reports indicate mTORi have been linked to...
3.
Siskind E, Amodu L, Liu C, Akerman M, Stodghill J, Wali R, et al.
HPB (Oxford)
. 2018 Sep;
21(2):195-203.
PMID: 30166090
Background: The decision to utilize portal or systemic venous drainage in pancreas transplantation is surgeon- and center-dependent. Information regarding the superior method is based on single-center reports and animal models....
4.
5.
Siskind E, Amodu L, Pinto S, Akerman M, Jonsson J, Molmenti E, et al.
Pancreas
. 2018 Apr;
47(5):625-630.
PMID: 29683972
Objectives: The method for drainage of exocrine secretions in pancreas transplantation remains a matter of debate. Different methods have evolved over time. Most data on these methods are from single-center...
6.
Wali R, Prentice H, Reddivari V, Baffoe-Bonnie G, Drachenberg C, Pappadimitriou J, et al.
Transplant Direct
. 2016 Nov;
2(9):e98.
PMID: 27795990
Background: Due to lack of treatment options for early acute allograft dysfunction in the presence of tubular-interstitial injury without histological features of rejection, kidney transplant recipients are often treated with...
7.
Estep J, OReilly L, Grant G, Piper J, Jonsson J, Afendy A, et al.
Dig Dis Sci
. 2009 Aug;
55(2):496-504.
PMID: 19680808
Background: Hepatic stellate cells (HSC) are involved in hepatic fibrogenesis. Cell signaling associated with an insult to the liver affects an HSC transdifferentiation to fibrogenic myofibroblast-like cells. Aims: To investigate...
8.
Arnadottir M, Jonsson E, Jonsson J
Transplantation
. 2006 Sep;
82(6):849.
PMID: 17006336
No abstract available.
9.
Kowalski R, Post D, Mannon R, Sebastian A, Wright H, Sigle G, et al.
Transplantation
. 2006 Sep;
82(5):663-8.
PMID: 16969290
Background: Long-term use of immunosuppressants is associated with significant morbidity and mortality in transplant recipients. A simple whole blood assay that has U.S. Food and Drug Administration clearance directly assesses...
10.
Vincenti F, Mendez R, Curtis J, Light J, Pearson T, Wu Y, et al.
Transplantation
. 2005 Oct;
80(7):910-6.
PMID: 16249738
Background: Monitoring cyclosporine microemulsion (CsA-ME; Neoral) exposure 2 hours postdose (C2) has been reported to optimize the efficacy and safety of CsA-ME therapy. The addition of induction therapy to a...